Multiple-drug resistant Acinetobacter baumannii bronchopneumonia in a colt following intensive care treatment

Equine Veterinary Education

Volumn 22, Issue 6, 2010, Pages 281-286

  Jokisalo, J ^a   Bryan, J ^a   Legget, B ^b   Abbott, Y ^b   Katz, L M ^a  

^a Section of Veterinary Clinical Studies   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Acinetobacter; Bronchopneumonia; Horse; Multiple drug resistance; Nosocomial

Indexed keywords

ACINETOBACTER; ACINETOBACTER BAUMANNII; ANIMALIA; EQUIDAE;

EID: 77954093856     PISSN: 09577734     EISSN: 20423292     Source Type: Journal    
DOI: 10.1111/j.2042-3292.2010.00071.x     Document Type: Article

References (45)

1. Abbott Y, O'Mahony R, Leonard N, Quinn PJ, van der Reijden T, Kijkshoorn L, Fanning S. Characterization of a 2.6 kbp variable region within a class 1 integron found in an Acinetobacter baumannii strain isolated from a horse. J. Antimicrob. Chemother. 2005, 55:367-370.
2. Amyes SG, Miles RS. Extended-spectrum beta-lactamases: The role of inhibitors in therapy. J. Antimicrob. Chemother. 1998, 42:415-417.
3. Anstey NM, Currie BJ, Hassell M, Palmer D, Dwyer B, Seifert H. Community-acquired bacteremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Acinetobacter baumannii, with carriage in the throat in at-risk groups. J. clin. Microbiol. 2002, 40:685-686.
4. Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 1996a, 9:148-165.
5. Bergogne-Berezin E, Towner KJ. Resistance of Acinetobacter spp. to antimicrobials-overview of clinical resistance patterns and therapeutic problems. Acinetobacter-Microbiology, Epidemiology, Infections, Management 1996b, 133-183. Bergogne-Berezin E, Joly-Guillou MLTowner KJ. In, Eds, CRC Press, Boca Raton, pp
6. Bernards AT, Frenay HME, Lim BT, Hendriks WDH, Kijkshoorn L, Boven CPA. Methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii: An unexpected difference in epidemiologic behavior. Am. J. Infect. Control. 1998, 26:544-551.
7. Blot S, Vandewoude K, Colardyn F. Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: A matched cohort study. Intens. Care Med. 2003, 29:471-475.
8. Boerlin A, Eugster C, Gaschen F, Straub R, Schawalder P. Transmission of opportunistic pathogens in a veterinary teaching hospital. Vet. Microbiol. 2001, 82:347-359.
9. Boguta L, Gradzki Z, Borges E, Maurin F, Kodjo A, Winiarczyk S. Bacterial flora in foals with upper respiratory tract infections in Poland. J. vet. Med. B 2002, 49:294-297.
10. Chen MZ, Hsueh PR, Lee LN, Yu CJ, Yang PC, Luh KT. Severe community-acquired pneumonia due to Acinetobacter baumannii. Chest 2001, 120:1072-1077.
11. Chu YW, Leung CM, Houang ET, Ng KC, Leung CB, Leung HY, Cheng AFB. Skin carriage of acinetobacters in Hong Kong. J. clin. Microbiol. 1999, 37:2962-2967.
12. Performance standards for antimicrobial disk susceptibility tests; approved standard. 2009, Clinical and Laboratory Standards Institute, 10th edn., CLSI document M02-AIO, vol 29, Eds, National committee, National Committee for Clinical and Laboratory Standards Institute, Wayne, Pennsylvania
13. Denton M, Wilcox MH, Parnell P, Green D, Keer V, Hawkey PM, Evans I, Murphy P. Role of environmental cleaning in controlling an outbreak of Acinetobacter baumannii on a neurosurgical intensive care unit. J. Hosp. Infect. 2004, 56:106-110.
14. Devaud M, Kayser FH, Bachi B. Transposon-mediated multiple antibiotic resistance in Acinetobacter strains. Antimicrob. Agents Chemother. 1982, 22:323-329.
15. Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 2007, 5:939-951.
16. Dijkshoorn L, Van Vianen W, Degener JE, Michel MF. Typing of Acinetobacter calcoaceticus strains isolated from hospital patients by cell envelope protein profiles. Epidemiol. Infect. 1987, 99:659-667.
17. Dijkshoorn L, Wubbels JL, Beunders AJ, Degener JE, Boks AL, Michel MF. Use of protein profiles to identify Acinetobacter calcoaceticus in a respiratory care unit. J. clin. Pathol. 1989, 42:853-857.
18. Falagas ME, Karveli EA, Kelesidis I, Kelesidis T. Community-acquired Acinetobacter infections. Eur. J. clin. Microbiol. infect. Dis. 2007, 26:857-868.
19. Fournier PE, Vallenet D, Barbe V, Audic S, Ogata H, Poirel L, Richet H, Robert C, Mangenot S, Abergel C, Nordmann P, Weissenbach J, Raoult D, Claverie JM. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet. 2006, 2:62-72.
20. Francey T, Gaschen F, Nicolet J, Burnens AP. The role of Acinetobacter baumannii as a nosocomial pathogen for dogs and cats in an intensive care unit. J. vet. intern. Med. 2000, 4:177-183.
21. Garcia-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J, Jimenez-Jimenez F-J, Perez-Paredes C, Barrero-Almodovar A, Gili-Miner M. Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study. Clin. Infect. Dis. 2001, 33:939-946.
22. Garnacho-Montero J, Ortiz-Leyba C, Fernández-Hinojosa E, Aldabó-Pallas T, Cauyela A, Marquez-Vácaro JA, Garcia-Curiel A, Jiménez-Jimenéz FJ. Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings. Intens. Care Med. 2005, 31:649-655.
23. Gaynes R, Edwards JR. Overview of nosocomial infections caused by Gram-negative bacilli. Clin. Infect. Dis. 2005, 41:848-854.
24. Giamarellou H, Antoniadou A, Kanellakopoulou K. Acinetobacter baumannii: a universal threat to public health? Int. J. antimicrob. Agents 2008, 32:106-119.
25. Jawad A, Seifert H, Snelling AM, Heritage J, Hawkey PM. Survival of Acinetobacter baumannii on dry surfaces: Comparison of outbreak and sporadic isolates. J. Clin. Microbiol. 1998, 36:1938-1941.
26. Johnson JA, Murtaugh RJ. Preventing and treating nosocomial infection. Part I. Urinary tract infections and pneumonia. Comp. cont. Educ. pract. Vet. 1997, 19:581-586.
27. Joly-Guillou ML. Clinical impact and pathogenicity of Acinetobacter. Clin. Microbiol. Infect. 2005, 11:868-873.
28. Joshi SG, Litake GM, Niphadkar KB, Ghole VS. Multidrug resistant Acinetobacter baumannii isolates from a teaching hospital. J. infect. Chemother. 2003, 9:187-190.
29. Karageorgopoulos DE, Falagas ME. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet infect. Dis. 2008, 8:751-762.
30. Katsaragakis S, Markogiannakis H, Toutouzas KG, Drimousis P, Larentzakis A, Theodoraki E-M, Theodorou D. Acinetobacter baumannii infections in a surgical intensive care unit: Predictors of multi-drug resistance. World J. Surg. 2008, 32:1194-1202.
31. Kester RM, Lesser S, Dowd LL. Bacteria isolated from equine respiratory cultures. Equine Pract. 1993, 15:33-36.
32. Melamed R, Greenberg D, Porat N, Karplus M, Zmora E, Golan A, Yagupsky P, Dagan R. Successful control of an Acinetobacter baumannii outbreak in a neonatal intensive care unit. J. Hosp. Infect. 2003, 53:31-38.
33. Ogeer-Gyles JS, Mathews KA, Boerling P. Nosocomial infections and antimicrobial resistance in critical care medicine. J. vet. Emerg. crit. Care 2006, 16:1-18.
34. Paul M, Weinberger M, Siegman-Igra Y, Lazarovitch T, Ostfeld I, Boldur I, Samra Z, Shula H, Carmeli Y, Rubinovitch B, Pitlik S. Acinetobacter baumannii: Emergence and spread in Israeli hospitals. 1997-2002. J. Hosp. Infect. 2005, 60:256-260.
35. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 2007, 51:3471-3484.
36. Poutanen SM, Louie M, Simor AE. Risk factors, clinical features and outcome of Acinetobacter bacteremia in adults. Eur. J. clin. Microbiol. infect. Dis. 1997, 16:737-740.
37. Racklyeft DJ, Love DN. Bacterial infection of the lower respiratory tract in 34 horses. Aust. vet. J. 2000, 78:549-559.
38. Saphir DA, Carter GR. Gingival flora of the dog with special reference to bacteria associated with bites. J. clin. Microbiol. 1976, 3:344-349.
39. Segal H, Thomas R, Elisha BG. Characterization of class 1 integron resistance gene cassettes and the identification of a novel IS-like element in Acinetobacter baumannii. Plasmid 2003, 49:169-178.
40. Seifert H, Dijkshoorn L, Gerner-Smidt P, Pelzer N, Tjernberg I, Vaneechoutte M. Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods. J. clin. Microbiol. 1997, 35:2819-2825.
41. Southwood LL. Principles of antimicrobial therapy: what should we be using? Vet. Clin. N. Am.: Equine Pract. 2006, 22:279-296.
42. Van den Broek PJ, Arends J, Bernards AT, De Brauwer E, Mascini EM, van der Reijden TJK, Spanjaard L, Thewessen EAPM, van der Zee A, van Zeijl JH, Dijkshoom L. Epidemiology of multiple Acinetobacter outbreaks in the Netherlands during the period 1999-2001. Clin. Microbiol. Infect. 2006, 12:837-843.
43. Vaneechoutte M, Devriese LA, Dijkshoorn L, Lamote B, Deprez P, Verschraegen G, Haesebrouck F. Acinetobacter baumannii-Infected Vascular Catheters Collected from Horses in an Equine Clinic. J. clin. Microb. 2000, 38:4280-4281.
44. Weese JS. A review of multidrug resistant surgical site infections. Vet. comp. Orthop. Traumatol. 2008, 21:1-7.
45. Wood JLN, Burrell MH, Roberts CA, Chanter N, Shaw Y. Streptococci and Pasteurella spp. associated with disease of the equine lower respiratory tract. Equine vet. J. 1993, 25:314-318.